Among the glycan and protein serum biomarkers, CA19-9, CEA, mucins, and osteopontin are representative in cancer diagnosis, especially in PC, breast cancer, and ovarian cancer. This evidence concerns the gene CEACAM5 and pachyonychia congenita.